J&J and Bavarian Nordic expand production of an Ebola vaccine program
October 22, 2014 at 02:19 AM EDT
Oct 22 (Reuters) - Johnson & Johnson said it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program.
